4S8-30242-84031
1 vaccination
1 coded response
15 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 945 / CA
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-11
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-12
Registered in v-safe
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · HeadacheAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-20
- 2021-04-25
- 2021-05-04
- 2021-05-11
- 2021-05-17
- 2021-05-25
- 2021-07-11
- 2021-10-11
-
2022-04-12
Survey response — 12 months, dose 1MedDRA: Cough, Dizziness, Nasopharyngitis, Nausea, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Couch, cold, fever, nausea, aches, dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-04-12
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-11 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-12 | Successful 2022-04-19 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 11 — 12 months, dose 1
Symptoms: Couch, cold, fever, nausea, aches, dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release